Source: Arcadia Biosciences Inc.

Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced that it has received a Fast-Track Small Business Innovation Research (SBIR) award worth $1.02 million from the U.S. National Institutes of Health (NIH) to further develop wheat with a high level of resistant starch. Under the award, Arcadia received Phase I funding of $144,000 and anticipates an additional Phase II award of $876,000 upon completion of its Phase I work.

Resistant starch is a type of starch that is not digested in the upper intestine, and is instead fermented in the large intestine. Because of this, the rapid rise in glucose levels after a meal is reduced and glucose is released more steadily into the bloodstream. This leads to an increased feeling of satiety over a longer time period. In addition, fermentation of resistant starch in the lower intestine leads to short chain fatty acid production, which promotes colon health. 

Original news release